Anbio Biotechnology (NNNN) KPIs and segments
Close on Nov 16, 2026Market cap $558.30MP/E 26.4Yield –
KPIs & segments
Operating metrics and segments that drive Anbio Biotechnology's business
Anbio Biotechnology's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
European Union($M) | 5.15 | 5.62 | 4.66 | 20.3 | |
Asia Pacific($M) | 1.52 | 0.51 | 0.07 | 3.19 | |
Other Regions($M) | 1.41 | 0.47 | 0.11 | ||
North America($M) | 0.30 | 0.11 | 0.22 | 0.05 | |
South America($M) | 0.27 | 1.48 | 1.65 | ||
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-04-07.
See a number that looks wrong?